CIRSE 2026: Two-year trial results support sirolimus-eluting balloon for patients with failing AVFs
Treatment with a sustained-release sirolimus-eluting balloon (SLR) for patients with failing arteriovenous fistulas (AVFs) was associated with higher target-lesion primary patency (TLPP) through to...
“Encouraging” early data shared from first kidney xenotransplant patients
eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, has announced clinical updates from an ongoing expanded access study...
Lower mortality risk seen with hemodiafiltration compared to conventional high-flux haemodialysis
Fresenius Medical Care (FME) has announced the publication of a large international study reporting that hemodiafiltration (HDF) was associated with lower relative risk of...
Phase 3 trial results of ATEV in AV access published in The Lancet Digital...
Humacyte has announced the publication of one-year results from the V007 phase 3 clinical trial of the acellular tissue engineered vessel (ATEV) in arteriovenous...
